Structure-Guided Design of a Small-Molecule Activator of Sirtuin-3 that Modulates Autophagy in Triple Negative Breast Cancer
Jin Zhang,Ling Zou,Danfeng Shi,Jie Liu,Jifa Zhang,Rongyan Zhao,Guan Wang,Lan Zhang,Liang Ouyang,Bo Liu
DOI: https://doi.org/10.1021/acs.jmedchem.0c02268
IF: 8.039
2021-10-03
Journal of Medicinal Chemistry
Abstract:Sirtuin-3 (SIRT3) is an NAD+-dependent protein deacetylase localized primarily in the mitochondria with many links to different types of human cancers. Autophagy, which is a highly conserved lysosomal degradation process in eukaryotic cells, has been recently reported to be positively regulated by SIRT3 in cancer; therefore, activating SIRT3-modulated autophagy may be a promising strategy for drug discovery. In this study, we discovered a small-molecule activator of SIRT3 compound 33c (ADTL-SA1215) with specific SIRT3 deacetylase activity by structure-guided design and high-throughput screening. Subsequently, compound 33c inhibited the proliferation and migration of human breast carcinoma MDA-MB-231 cells by SIRT3-driven autophagy/mitophagy signaling pathways in vitro and in vivo. Collectively, these results demonstrate that pharmacological activation of SIRT3 is a potential therapeutic approach of triple negative breast cancer (TNBC). More importantly, compound 33c may be a first-in-class specific small-molecule activator of SIRT3 that would be utilized for future cancer drug development.The Supporting Information is available free of charge at https://pubs.acs.org/doi/10.1021/acs.jmedchem.0c02268.Representative crystal structures of SIRT3 in complex with cofactors, substrates, and ligands; predicted binding sites for different SIRT proteins; possible binding sites near NAD+; 100 ns molecular dynamics simulation of system 1 (SIRT3 + NAD+) and system 2 (SIRT3 + NAD+ + substrate); molecular docking of top 20 compounds with SIRT3 pocket U; binding mode of ZINC03830212 and SIRT3 in chain B; comparison of SIRT3 deacetylation activity of resveratrol, honokiol, and 33c; sequence alignment of SIRT1, SIRT2, SIRT3, and SIRT5; binding modes of 33c with SIRT1, SIRT2, SIRT3, and SIRT5; western blot analysis of the acetylation and succinylation level of cellular mitochondria extracts after 33c treatment ; binding sites on SIRT3 for different ligands compared with ZINC03830212 and 33c; effect of ZINC03830212 and 33c on MCF10A cells; HE staining of the lungs taken from TNBC xenograft mice; top 20 compounds based upon Pocket U screening; original data of co-immunoprecipitation and western blot; HPLC, MS, and NMR data (PDF)Molecular formula strings and the associated biochemical and biological data (CSV)This article has not yet been cited by other publications.
chemistry, medicinal